Company Profile: Hansen Medical develops medical robotics designed for accurate positioning, manipulation and control of catheters and catheter-based technologies.Shares of Hansen Medical jumped to a 52-week high of $5.28 in July, but the rally began in early February after Philips Electronics purchased the rights to develop and market Hansen Medical's Fiber Optic Shape Sensing and Localization, or FOSSL, technology for an upfront payment of $29 million. Hansen Medical is also eligible for $78 million in future payments. Current Share Price: $3.49 (Sept. 28) 2011 Total Return: 129.5% Analyst Ratings: JPMorgan and Lazard Capital analysts rate Hansen Medical a "neutral," while Piper Jaffray and Ladenburg Thalmann analysts say the stock is a "buy." The average price target of $4.75 represents potential upside of 36%. TheStreet Ratings rates Hansen Medical a "sell," calling special attention to the company's weak operating cash flow.
4. Interphase (INPH - Get Report) Company Profile: Interphase is a telecom-equipment maker. The company provides services for LTE and WiMAX, interworking gateways, packet processing, network connectivity, and security for key applications for the communications and enterprise markets. Interphase shares more than doubled on Feb. 11, a day after the company reported fourth-quarter financial results. The company said revenue in the quarter jumped 24% to $5.8 million as it swung to a quarterly profit. The stock hit a high of $7.59 in March but has been steadily pulling back since. Current Share Price: $4.68 (Sept. 28) 2011 Total Return: 162.2% Analyst Ratings: There are no research firms covering Interphase currently. TheStreet Ratings has a "sell" rating on the stock, which it has maintained since downgrading the stock from "hold" in July 2009. The latest report says Interphase's primary weakness is "feeble growth in its earnings per share."